MacLean Alexandra 4
4 · AVENUE THERAPEUTICS, INC. · Filed Jul 3, 2023
Insider Transaction Report
Form 4
MacLean Alexandra
Chief Executive Officer
Transactions
- Award
Employee stock option (right to buy)
2023-06-29+800,000→ 800,000 totalExercise: $1.14Exp: 2033-06-29→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.